Published in Br J Pharmacol on January 01, 2003
Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res (2013) 1.62
Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension (2011) 1.60
Beta-adrenoceptor polymorphisms. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.09
Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism (2007) 1.08
Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.00
Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases. Br J Pharmacol (2009) 0.99
Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors. Br J Pharmacol (2004) 0.96
Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms. PLoS One (2012) 0.94
The functional significance of genetic variation within the beta-adrenoceptor. Br J Clin Pharmacol (2005) 0.93
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation. Eur J Heart Fail (2012) 0.84
Confirmation of a role for the 389R>G beta-1 adrenoceptor polymorphism on exercise capacity in heart failure. Heart (2005) 0.78
The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.78
Functional effects of β₁-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration. Clin Res Cardiol (2010) 0.78
Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy. Pediatr Res (2014) 0.78
RAAS and adrenergic genes in heart failure: Function, predisposition and survival implications. World J Cardiol (2010) 0.77
The effect of beta1-adrenergic receptor gene polymorphism on prolongation of corrected QT interval during endotracheal intubation under sevoflurane anesthesia. Korean J Anesthesiol (2011) 0.75
Receptor gene polymorphisms: lessons on functional relevance from the beta 1-adrenoceptor. Br J Pharmacol (2003) 0.75
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res (1991) 6.26
A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem (1999) 2.78
A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J (2000) 1.96
The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) (2000) 1.64
Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium. Circ Res (1990) 1.57
A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet (2002) 1.46
Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol (2002) 1.38
Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet (1999) 1.36
Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation (2001) 1.35
Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics (2001) 1.28
A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J (1989) 1.23
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics (2001) 1.21
Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol Pharmacol (1994) 1.05
Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes. Br J Clin Pharmacol (1989) 1.01
Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues. Biochem J (1990) 1.00
Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med (Berl) (2000) 0.99
Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors. Br J Pharmacol (1997) 0.95
Human tissue adrenergic receptors are not predictive of responses to epinephrine in vivo. Am J Physiol (1989) 0.94
Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J Mol Med (Berl) (1998) 0.94
Influence of beta1-adrenoceptor blockade on the gene expression of adenylate cyclase subtypes and beta-adrenoceptor kinase in human atrium. Clin Sci (Lond) (2001) 0.86
Influence of age on left atrial appendage function in patients with nonvalvular atrial fibrillation. Clin Cardiol (2001) 0.81
Differences in transcription and translation of long and short Gs alpha, the stimulatory G-protein, in human atrium. Clin Sci (Lond) (1995) 0.81
Left Ventricular Diastolic Function in a Population Sample of Elderly Men. Echocardiography (1998) 0.81
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens (2004) 8.32
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol (2000) 5.55
Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX. Science (2000) 3.95
Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet (1999) 3.69
Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med (1983) 3.52
Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med (1983) 3.27
Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J Immunol (1999) 3.06
Lead poisoning among refugee children resettled in Massachusetts, 1995 to 1999. Pediatrics (2001) 2.58
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest (1999) 2.58
Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci (Lond) (1981) 2.52
Childhood lead poisoning in Massachusetts communities: its association with sociodemographic and housing characteristics. Am J Public Health (1995) 2.39
Grommets and glue ear: a five-year follow up of a controlled trial. J R Soc Med (1978) 2.31
A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK. Circulation (1999) 2.29
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Influence of age on general practitioners' definition and treatment of hypertension. BMJ (1995) 2.16
Angiotensin-converting enzyme and the cough reflex. Lancet (1987) 1.94
Cytosine arabinoside in the treatment of acute myeloblastic leukaemia. Lancet (1971) 1.94
A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax (1981) 1.90
Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart. Circ Res (1989) 1.82
Benign sickle-cell anaemia. Lancet (1972) 1.79
Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis. Neurology (2008) 1.78
Effects of adrenaline and of spontaneous labour on the secretion and absorption of lung liquid in the fetal lamb. J Physiol (1983) 1.77
Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77
A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol (1990) 1.76
Circulating catecholamines in acute asthma. Br Med J (Clin Res Ed) (1985) 1.73
Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM (1999) 1.71
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) (2000) 1.64
Selective arterial embolization. A new method for control of acute gastrointestinal bleeding. Radiology (1972) 1.62
Model-based drug development: a rational approach to efficiently accelerate drug development. Clin Pharmacol Ther (2013) 1.57
Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium. Circ Res (1990) 1.57
Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J Cardiovasc Pharmacol (1989) 1.57
A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics. J Allergy Clin Immunol (1982) 1.56
The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure (2001) 1.54
A new opportunity for training in clinical pharmacology. Br J Clin Pharmacol (1996) 1.52
Selective suprasensitivity to calcitonin-gene-related peptide in the hands in Raynaud's phenomenon. Lancet (1989) 1.50
Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet (1997) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Role of venous sampling in locating a phaeochromocytoma. Br Med J (Clin Res Ed) (1983) 1.45
Catamenial mononeuropathy and radiculopathy: a treatable neuropathic disorder. J Neurosurg (1998) 1.45
mRNA quantification by real time TaqMan polymerase chain reaction: validation and comparison with RNase protection. Anal Biochem (1999) 1.44
Diabetic neuropathy. Ann Neurol (1984) 1.44
Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet (1981) 1.42
A hybrid modular polyketide synthase obtained by domain swapping. Chem Biol (1996) 1.42
Mortality in the CHAOS trial. Lancet (1999) 1.41
Palatal myoclonus affected by neck position. J Laryngol Otol (1995) 1.41
Repositioning of a domain in a modular polyketide synthase to promote specific chain cleavage. Science (1995) 1.41
A comparison of parametric and non-parametric approaches to target-controlled infusion of propofol. Anaesth Intensive Care (2010) 1.39
Serum hepatitis in a haemophiliac. Br Med J (1969) 1.38
Lessons in the diagnosis and management of Conn's syndrome. Clin Med (2007) 1.38
Males of social insects can prevent queens from multiple mating. Proc Biol Sci (2001) 1.35
Hazards of 'deleading' homes of children with lead poisoning. Am J Dis Child (1987) 1.34
Blunted sympathoadrenal response to exercise in asthmatic subjects. Br J Dis Chest (1982) 1.31
A 5-HT4-like receptor in human right atrium. Naunyn Schmiedebergs Arch Pharmacol (1991) 1.27
Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br J Pharmacol (1986) 1.27
Experimental allergic neuritis induced by sensitization with galactocerebroside. Science (1979) 1.26
Adrenaline and hypertension. Clin Exp Hypertens A (1984) 1.26
In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study. Am J Pathol (1979) 1.25
Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest (1978) 1.25
Monoclonal immunoassays for major dust mite (Dermatophagoides) allergens, Der p I and Der f I, and quantitative analysis of the allergen content of mite and house dust extracts. J Allergy Clin Immunol (1987) 1.25
Syntaxin 11 is associated with SNAP-23 on late endosomes and the trans-Golgi network. J Cell Sci (1999) 1.24
Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J Exp Med (2000) 1.23
N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals. J Appl Physiol (1985) (2004) 1.23
A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J (1989) 1.23
Transfer of demyelination by intraneural injection of experimental allergic neuritis serum. Nature (1978) 1.23
Functioning middle mediastinal paraganglioma (phaeochromocytoma) associated with intercarotid paragangliomas. Lancet (1986) 1.22
Venous plasma histamine in exercise- and hyperventilation-induced asthma in man. Clin Sci (Lond) (1981) 1.21
GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. FEBS Lett (2001) 1.21
Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab (1985) 1.21
Home abatement and blood lead changes in children with class III lead poisoning. Clin Pediatr (Phila) (1994) 1.20
A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J Biol Chem (2001) 1.19
A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. Br J Clin Pharmacol (1981) 1.19
Rapid changes in plasma potassium during a game of squash. Clin Sci (Lond) (1988) 1.18
Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics. J Allergy Clin Immunol (1982) 1.18
Pulmonary embolism: prospective comparison of spiral CT with ventilation-perfusion scintigraphy. Radiology (1997) 1.17
N-acetylcysteine infusion alters blood redox status but not time to fatigue during intense exercise in humans. J Appl Physiol (1985) (2002) 1.17
A sensitive and specific radiometric method for the measurement of plasma histamine in normal individuals. Anal Biochem (1980) 1.16
Distal neuropathy in experimental diabetes mellitus. Ann Neurol (1980) 1.15
Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Lond) (1986) 1.15
Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest (1990) 1.13
Residential deleading: effects on the blood lead levels of lead-poisoned children. Pediatrics (1991) 1.12
The methylerythritol phosphate pathway and its significance as a novel drug target. Curr Pharm Biotechnol (2003) 1.11
The Src homology 2 domain of Vav is required for its compartmentation to the plasma membrane and activation of c-Jun NH(2)-terminal kinase 1. J Exp Med (2000) 1.11
The effects of nifedipine and hydralazine induced hypotension on sympathetic activity. Eur J Clin Pharmacol (1982) 1.10
Synthetic studies of nucleic acids on polymer supports. I. Oligodeoxyribonucleotide synthesis on an insoluble polymer support. J Chem Soc Perkin 1 (1967) 1.10
Hypokalemia from beta 2-receptor stimulation by circulating epinephrine. Am J Cardiol (1985) 1.10
The heritability of plasma homocysteine, and the influence of genetic variation in the homocysteine methylation pathway. QJM (2007) 1.09
Noise exposure and hearing loss among student employees working in university entertainment venues. Ann Occup Hyg (2002) 1.08
Equivalent-circuit model for the thickness-shear mode resonator with a viscoelastic film near film resonance. Anal Chem (2000) 1.07
Concentration effect relationships of infused histamine in normal volunteers. Agents Actions (1982) 1.07
Phaeochromocytoma with associated somatostatin production. BMJ (1989) 1.07
Is adrenaline the cause of essential hypertension? Lancet (1981) 1.06
Poisoned landscapes: the epidemiology of environmental lead exposure in Massachusetts children 1990-1991. Soc Sci Med (1994) 1.06
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma. Eur J Endocrinol (2007) 1.05
Management of hypertension in general practice: agreements with and variations from the British Hypertension Society guidelines. J Hum Hypertens (1995) 1.05
Homocysteine levels and leukocyte telomere length. Atherosclerosis (2008) 1.05